These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study. Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992 [TBL] [Abstract][Full Text] [Related]
48. Role of mirtazapine in the treatment of antipsychotic-induced akathisia. Hieber R; Dellenbaugh T; Nelson LA Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588 [TBL] [Abstract][Full Text] [Related]
50. Use of clonidine in treating neuroleptic-induced akathisia. Zubenko GS; Cohen BM; Lipinski JF; Jonas JM Psychiatry Res; 1984 Nov; 13(3):253-9. PubMed ID: 6152054 [TBL] [Abstract][Full Text] [Related]
51. Clozapine-induced akathisia in children with schizophrenia. Gogtay N; Sporn A; Alfaro CL; Mulqueen A; Rapoport JL J Child Adolesc Psychopharmacol; 2002; 12(4):347-9. PubMed ID: 12625995 [TBL] [Abstract][Full Text] [Related]
52. Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia. Poyurovsky M; Weizman A Int Clin Psychopharmacol; 1999 Nov; 14(6):357-60. PubMed ID: 10565803 [TBL] [Abstract][Full Text] [Related]
54. L-tryptophan in neuroleptic-induced akathisia. Kramer MS; DiJohnson C; Davis P; Dewey DA; DiGiambattista S Biol Psychiatry; 1990 Mar; 27(6):671-2. PubMed ID: 1969752 [No Abstract] [Full Text] [Related]
55. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin. Miller CH; Fleischhacker WW; Ehrmann H; Kane JM Psychopharmacol Bull; 1990; 26(3):373-6. PubMed ID: 1980375 [TBL] [Abstract][Full Text] [Related]
56. Successful treatment with clonazepam for neuroleptic-induced akathisia. Horiguchi J; Nishimatsu O; Inami Y Acta Psychiatr Scand; 1989 Jul; 80(1):106-7. PubMed ID: 2569804 [TBL] [Abstract][Full Text] [Related]
57. Risk factors for the development of neuroleptic induced akathisia. Miller CH; Hummer M; Oberbauer H; Kurzthaler I; DeCol C; Fleischhacker WW Eur Neuropsychopharmacol; 1997 Feb; 7(1):51-5. PubMed ID: 9088885 [TBL] [Abstract][Full Text] [Related]
59. Placebo response in refractory tardive akathisia. Remington G; Fornazzari L; Sethna R Can J Psychiatry; 1993 May; 38(4):248-50. PubMed ID: 8100184 [TBL] [Abstract][Full Text] [Related]
60. Opioids a better treatment for acute than tardive akathisia: possible role for the endogenous opiate system in neuroleptic-induced akathisia. Walters AS; Hening A Med Hypotheses; 1989 Jan; 28(1):1-2. PubMed ID: 2564626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]